Matthew M Lei (Mathew Lei, Matthew Lei)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 16

Top Venues

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Blood advances

Massachusetts General Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Massachusetts General Hospital Aug 05 2017

United States

Clinical Pharmacist, Medical Oncology :: Pharmacy

Publications

Matthew M Lei, Mark N Sorial, Uvette Lou, Michelle Yu, Andrea Medrano, Josie Germain Ford, Ronald A Nemec, Jeremy S Abramson, Jacob D Soumerai
Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. Leukemia & lymphoma 65 (5) (2024)
Matthew M Lei, Qianyi Li, Ken O'Day, Kellie Meyer, Anthony Wang, Monika P Jun
Practice efficiency and total cost of care with bispecifics and CAR-T in relapsed/refractory diffuse large B-cell lymphoma: an institutional perspective 1 . Future oncology (London, England) (2024)
Matthew M Lei, Mark N Sorial, Uvette Lou, Michelle Yu, Andrea Medrano, Josie Germain Ford, Ronald A Nemec, Jeremy S Abramson, Jacob D Soumerai
Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. Leukemia & lymphoma (2024)
Matthew M Lei, Qianyi Li, Ken O'Day, Kellie Meyer, Anthony Wang, Monika P Jun
Practice efficiency and total cost of care with bispecifics and CAR-T in relapsed/refractory diffuse large B-cell lymphoma: an institutional perspective 1 . Future oncology (London, England) (2024)
Matthew M Lei, Mark N Sorial, Uvette Lou, Michelle Yu, Andrea Medrano, Josie Germain Ford, Ronald A Nemec, Jeremy S Abramson, Jacob D Soumerai
Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. Leukemia & lymphoma 65 (5) (2024)
Matthew M Lei, Mark N Sorial, Uvette Lou, Michelle Yu, Andrea Medrano, Josie Germain Ford, Ronald A Nemec, Jeremy S Abramson, Jacob D Soumerai
Real-world evidence of obinutuzumab and venetoclax in previously treated patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. Leukemia & lymphoma 65 (5) (2024)
Matthew M Lei, Qianyi Li, Ken O'Day, Kellie Meyer, Anthony Wang, Monika P Jun
Practice efficiency and total cost of care with bispecifics and CAR-T in relapsed/refractory diffuse large B-cell lymphoma: an institutional perspective. Future oncology (London, England) (2024)
Matthew M Lei, Qianyi Li, Ken O'Day, Kellie Meyer, Anthony Wang, Monika P Jun
Practice efficiency and total cost of care with bispecifics and CAR-T in relapsed/refractory diffuse large B-cell lymphoma: an institutional perspective. Future oncology (London, England) (2024)
Robert A Redd, Josie Ford, Matthew M Lei, Jeremy S Abramson, Jacob D Soumerai
Combined analysis of the impact of second-generation BTK inhibitors on patient outcomes. Leukemia & lymphoma (2023)
J Erika Haydu, Jenny S Maron, Robert A Redd, Kathleen M E Gallagher, Stephanie Fischinger, Jeffrey A Barnes, Ephraim P Hochberg, P Connor Connor Johnson, R W Takvorian, Katelin Katsis, Daneal Portman, Jade Ruiters, Sidney Sechio, Mary Devlin, Connor Regan, Kimberly G Blumenthal, Aleena Banerji, Allen D Judd, Krista J Scorsune, Brianne M McGree, Maryanne M Sherburne, Julia M Lynch, James I Weitzman, Matthew M Lei, Camille Nelson Kotton, Anand S Dighe, Marcela V Maus, Galit Alter, Jeremy S Abramson, Jacob D Soumerai
Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study. Blood advances 6 (6) (2022)
Jacob D Soumerai, Allison Rosenthal, Shannon K Harkins, Jessica Duffy, Carmen Mecca, Yingbing Wang, Ravinder K Grewal, Areej R El-Jawahri, Huiyun Liu, Cedric Menard, Ahmet Dogan, Lei Yang, Lisa M Rimsza, Kurt Bantilan, Haley Martin, Matthew M Lei, Sydney Mohr, Anna Kurilovich, Olga Mikhaylovna Plotnikova, Ekaterina Postovalova, Valentina Nardi, Jeremy S Abramson, Roberto Chiarle, Andrew D Zelenetz, Abner Louissaint
Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma. Blood 140 (16) (2022)
Jack Malespini, Matthew M Lei, Erica Tavares, Sarah P Hammond, Yi-Bin Chen, Samantha O Luk, Zachariah DeFilipp
Letermovir and tacrolimus interaction effects in hematopoietic cell transplantation recipients receiving moderate cytochrome P450 3A4 inhibitors for antifungal prophylaxis. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Matthew M Lei, Erica Tavares, Evan Buzgo, Uvette Y Lou, Noopur Raje, Andrew J Yee
Denosumab versus intravenous bisphosphonate use for hypercalcemia in multiple myeloma. Leukemia & lymphoma (2022)
Emma Uchida, Matthew M Lei, Eric Roeland, Uvette Lou
Evaluating the incidence of chemotherapy-induced nausea and vomiting in patients with B-cell lymphoma receiving dose-adjusted EPOCH and rituximab. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 28 (1) (2021)
Andrew R Branagan, Matthew M Lei, Steven P Treon, Jorge J Castillo
Clinical application of genomics in Waldenström macroglobulinemia. Leukemia & lymphoma 62 (8) (2021)
Matthew M Lei, Aleksandra N Watson, Jeremy S Abramson
Evaluation of the impact of timing of pegfilgrastim administration on incidence of febrile neutropenia in elderly patients with B-cell non-Hodgkin lymphomas receiving R-CHOP-21. Leukemia & lymphoma 61 (12) (2020)

Matthew M Lei.css-eqlu8i{font-size:small;padding-left:4px;} (Mathew Lei, Matthew Lei)

Publication Activity (10 Years)

Top Topics

Top Venues

Matthew M Lei (Mathew Lei, Matthew Lei)